Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ADT on Muscle Metabolism in Prostate Cancer
NCT03440879Terminated
- Sponsor
- Norwegian School of Sport Sciences
- Start
- Sep 2018
- Primary completion
- Mar 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of goserelin in prostate cancer (PCa) (2 arms), sponsored by Norwegian School of Sport Sciences. Primary endpoint: Muscle protein synthesis rate. Started Sep 2018; status: terminated.
02
Drugs
goserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03440879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03440879.